QTRX
NASD Quanterix Corporation$3.71 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.71, $0.01 below the day’s high of $3.72
- YTD change
- -41.67%
- vs 20-day SMA
- +27.54%
- vs 200-day SMA
- -13.73%
Price ranges
Price & Performance
+0.23 (+6.61%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 96.0% away from all-time highs of $92.57
- QTRX is down 42% since the beginning of the year
- QTRX is down 32% over the past 12 months
- QTRX is up 39% over the past 1 month
- 12% of all QTRX investors are betting against QTRX
QTRX reads very good: price sits above one of the two key moving averages, the 12-month move is -33.0%.
- Previous minute
- +$0.01
- Last hour
- +$0.07
- Last 5 days
- +16.30%
- vs 8-day SMA
- +13.72%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.